Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supporting-like cells constitute an alternative steroidogenic lineage conserved in amniotes.

bioRxiv : the preprint server for biology·2026
Same author

Neddylation blockade protects endothelial cells against inflammation and ischemia-reperfusion injuries.

Cell communication and signaling : CCS·2026
Same author

What are the vectors in European livestock farms? Case studies in Hungary and Spain.

Parasites & vectors·2026
Same author

IgA-Producing B Cells Exert Regulatory Function through Granzyme B in Kidney Allograft Tolerance.

Kidney360·2026
Same author

A gene-expression module identifies circulating immune cells with enhanced recruitment to sites of inflammation.

iScience·2026
Same author

An autosomal recessive nonsense variant in the EGFR gene induces perinatal lethality in "Blonde d'Aquitaine" calves.

BMC veterinary research·2026

Related Experiment Video

Updated: Jul 6, 2026

RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus
06:57

RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus

Published on: October 16, 2011

Prnp knockdown in transgenic mice using RNA interference.

Micaela Gallozzi1, Jérome Chapuis, Fabienne Le Provost

  • 1UR 339, Laboratoire de Génétique Biochimique et de Cytogénétique, Institut National de la Recherche Agronomique, 78350, Jouy-en-Josas, France.

Transgenic Research
|March 20, 2008
PubMed
Summary

RNA interference effectively reduced prion protein gene expression in mice. This gene knockdown approach shows promise for disease resistance, though expression levels impact efficiency.

More Related Videos

RNAi Trigger Delivery into Anopheles gambiae Pupae
09:58

RNAi Trigger Delivery into Anopheles gambiae Pupae

Published on: March 8, 2016

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
08:27

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Published on: April 10, 2018

Related Experiment Videos

Last Updated: Jul 6, 2026

RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus
06:57

RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus

Published on: October 16, 2011

RNAi Trigger Delivery into Anopheles gambiae Pupae
09:58

RNAi Trigger Delivery into Anopheles gambiae Pupae

Published on: March 8, 2016

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
08:27

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Published on: April 10, 2018

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • RNA interference (RNAi) is a powerful tool for gene knockdown in various organisms.
  • The prion protein (PrP) is implicated in neurodegenerative diseases.

Purpose of the Study:

  • To develop and test an RNA interference strategy targeting the prion protein mRNA.
  • To assess the efficacy of this approach in reducing endogenous Prnp gene expression in transgenic mice.

Main Methods:

  • Designed a microRNA (miRNA) targeting prion protein mRNA.
  • Expressed the miRNA using the human PRNP promoter in cell cultures and transgenic mice.
  • Quantified Prnp gene expression levels in transfected cells and mouse lines.

Main Results:

  • Confirmed miRNA efficiency in transfected cells.
  • Generated several transgenic mouse lines expressing the designed miRNA.
  • Observed significant downregulation of endogenous mouse Prnp gene expression, up to 80% inhibition.
  • Found a correlation between transgene expression level and Prnp gene downregulation.

Conclusions:

  • RNA interference is a viable strategy for targeting Prnp gene expression.
  • The efficiency of RNAi-mediated gene knockdown is dependent on transgene expression levels.
  • This approach holds potential for developing disease resistance strategies against prion diseases, with noted limitations.